Stephen Johnson

Array ( [id] => 5845460 [patent_doc_number] => 20020132846 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-19 [patent_title] => 'Use of gamma substituted gamma-butyrolactones to increase levels of their corresponding substituted gamma-hydroxybutyrate derivatives in humans' [patent_app_type] => new [patent_app_number] => 10/081516 [patent_app_country] => US [patent_app_date] => 2002-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 816 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20020132846.pdf [firstpage_image] =>[orig_patent_app_number] => 10081516 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6451561 [patent_doc_number] => 20020177619 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-28 [patent_title] => 'Steroid sulphatase inhibitors' [patent_app_type] => new [patent_app_number] => 10/082007 [patent_app_country] => US [patent_app_date] => 2002-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 4807 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20020177619.pdf [firstpage_image] =>[orig_patent_app_number] => 10082007 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6381910 [patent_doc_number] => 20020120002 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-29 [patent_title] => 'Use of melatonin analogues for induction of general anesthesia' [patent_app_type] => new [patent_app_number] => 10/078643 [patent_app_country] => US [patent_app_date] => 2002-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3911 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20020120002.pdf [firstpage_image] =>[orig_patent_app_number] => 10078643 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6159124 [patent_doc_number] => 20020147220 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-10 [patent_title] => 'Methods for treating apnea and apnea disorders using optically pure (+) norcisapride' [patent_app_type] => new [patent_app_number] => 10/075617 [patent_app_country] => US [patent_app_date] => 2002-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7791 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20020147220.pdf [firstpage_image] =>[orig_patent_app_number] => 10075617 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5987622 [patent_doc_number] => 20020099082 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-25 [patent_title] => 'Use of glucose uptake enhancer for reducing apoptosis' [patent_app_type] => new [patent_app_number] => 10/072098 [patent_app_country] => US [patent_app_date] => 2002-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5093 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20020099082.pdf [firstpage_image] =>[orig_patent_app_number] => 10072098 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5969051 [patent_doc_number] => 20020091103 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-11 [patent_title] => 'Omega-3 fatty acids and omega-3 phosphatidylcholine in the treatment of bipolar disorder' [patent_app_type] => new [patent_app_number] => 10/068035 [patent_app_country] => US [patent_app_date] => 2002-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3222 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20020091103.pdf [firstpage_image] =>[orig_patent_app_number] => 10068035 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6159107 [patent_doc_number] => 20020147214 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-10 [patent_title] => 'Heterocyclic compounds' [patent_app_type] => new [patent_app_number] => 10/062647 [patent_app_country] => US [patent_app_date] => 2002-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35658 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20020147214.pdf [firstpage_image] =>[orig_patent_app_number] => 10062647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1356166 [patent_doc_number] => 06576646 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-10 [patent_title] => 'Methods for treating cognitive impairments caused by traumatic brain injuries' [patent_app_type] => B1 [patent_app_number] => 10/054931 [patent_app_country] => US [patent_app_date] => 2002-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4995 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/576/06576646.pdf [firstpage_image] =>[orig_patent_app_number] => 10054931 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6788229 [patent_doc_number] => 20030139468 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-24 [patent_title] => 'Amiodarone solutions suitable for intravenous administration' [patent_app_type] => new [patent_app_number] => 10/054493 [patent_app_country] => US [patent_app_date] => 2002-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2199 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0139/20030139468.pdf [firstpage_image] =>[orig_patent_app_number] => 10054493 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5936634 [patent_doc_number] => 20020061867 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-23 [patent_title] => 'Prevention of ovarian cancer by administration of a Vitamin D compound' [patent_app_type] => new [patent_app_number] => 10/051662 [patent_app_country] => US [patent_app_date] => 2002-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7536 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20020061867.pdf [firstpage_image] =>[orig_patent_app_number] => 10051662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6847561 [patent_doc_number] => 20030166728 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Prostacyclin derivative containing compositions and methods of using the same for the treatment of cancer' [patent_app_type] => new [patent_app_number] => 10/047802 [patent_app_country] => US [patent_app_date] => 2002-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9937 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20030166728.pdf [firstpage_image] =>[orig_patent_app_number] => 10047802 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6278618 [patent_doc_number] => 20020107225 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-08 [patent_title] => 'Methods of treating leukemia' [patent_app_type] => new [patent_app_number] => 10/046289 [patent_app_country] => US [patent_app_date] => 2002-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5042 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20020107225.pdf [firstpage_image] =>[orig_patent_app_number] => 10046289 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5987435 [patent_doc_number] => 20020099044 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-25 [patent_title] => 'Composition comprising amoxycillin and clavulanic acid' [patent_app_type] => new [patent_app_number] => 10/043437 [patent_app_country] => US [patent_app_date] => 2002-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2721 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20020099044.pdf [firstpage_image] =>[orig_patent_app_number] => 10043437 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1389475 [patent_doc_number] => 06548550 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-15 [patent_title] => 'Pharmaceutical compositions containing N-palmitoylethanolamide and use thereof in the veterinary field' [patent_app_type] => B1 [patent_app_number] => 10/030060 [patent_app_country] => US [patent_app_date] => 2002-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2272 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/548/06548550.pdf [firstpage_image] =>[orig_patent_app_number] => 10030060 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6736129 [patent_doc_number] => 20030013764 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-16 [patent_title] => 'Use for a pyruvate dehydrogenase activator for the treatment of ischaemia in limbs' [patent_app_type] => new [patent_app_number] => 10/024476 [patent_app_country] => US [patent_app_date] => 2001-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4493 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20030013764.pdf [firstpage_image] =>[orig_patent_app_number] => 10024476 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6721382 [patent_doc_number] => 20030055072 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-20 [patent_title] => 'Methods of inhibiting Pin1-associated states using a fredericamycin a compound' [patent_app_type] => new [patent_app_number] => 10/027864 [patent_app_country] => US [patent_app_date] => 2001-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 15149 [patent_no_of_claims] => 91 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20030055072.pdf [firstpage_image] =>[orig_patent_app_number] => 10027864 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1531190 [patent_doc_number] => 06488164 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-12-03 [patent_title] => 'Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue' [patent_app_type] => B2 [patent_app_number] => 10/029306 [patent_app_country] => US [patent_app_date] => 2001-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5484 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/488/06488164.pdf [firstpage_image] =>[orig_patent_app_number] => 10029306 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7622233 [patent_doc_number] => 06977268 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-12-20 [patent_title] => 'Methods and compositions for inhibition of angiogenesis with EM-138' [patent_app_type] => utility [patent_app_number] => 10/026037 [patent_app_country] => US [patent_app_date] => 2001-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 6909 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/977/06977268.pdf [firstpage_image] =>[orig_patent_app_number] => 10026037 [rel_patent_id] =>[rel_patent_doc_number] =>)